Annual report pursuant to Section 13 and 15(d)

Significant Accounting Policies (Details)

v3.8.0.1
Significant Accounting Policies (Details)
1 Months Ended 3 Months Ended 12 Months Ended
Aug. 14, 2017
USD ($)
Aug. 31, 2017
USD ($)
Dec. 31, 2017
USD ($)
Sep. 30, 2017
USD ($)
Jun. 30, 2017
USD ($)
Mar. 31, 2017
USD ($)
Sep. 30, 2013
USD ($)
Dec. 31, 2017
USD ($)
class_of_stock
segment
product_line
shares
Jun. 30, 2017
USD ($)
Apr. 30, 2017
USD ($)
Dec. 31, 2016
USD ($)
class_of_stock
shares
Dec. 31, 2015
USD ($)
Net Loss Per Share, Basic and Diluted                        
Anti- dilutive securities excluded from the computation of diluted weighted shares outstanding | shares               0     0  
Escrowed Cash Receivable [Abstract]                        
Proceeds on sale of rights $ 25,000,000 $ 25,000,000 $ 0 $ 25,000,000 $ 0 $ 0   $ 25,000,000     $ 0 $ 0
Escrowed cash receivable $ 3,750,000 $ 3,750,000 3,752,390         3,752,390     0  
Escrow period 12 months 12 months                    
Reserve on escrow receivable     0         0        
Restricted Cash                        
Deposits                     50,000  
Security deposit required, end of third year             $ 13,000          
Accounts Receivable                        
Allowance for Doubtful Accounts Receivable     0         $ 0        
Accounts Receivable, Payment Terms               30 days        
Sales discounts, percent               2.00%        
Sales discounts, amount               $ 57,705        
Inventory                        
Reserves for excess and obsolete inventory     178,346         178,346     0  
Intangible Assets                        
Impairment of Intangible Assets, Finite-lived               0        
Grant Revenue [Abstract]                        
Revenue recognized on grant     45,000 38,000 158,000 384,000   624,569     1,152,987 0
Concentration Risk                        
Product revenue, net     1,911,000 $ 0 $ 0 $ 0   $ 1,910,403     $ 0 $ 0
Number of product lines | product_line               5        
Clinical Trial Expense Accruals                        
Number of material adjustments to prior period estimates of accrued expenses | class_of_stock               0     0  
Segment Reporting Information, Additional Information [Abstract]                        
Number of operating segments | segment               1        
Equipment                        
Property, Plant and Equipment [Abstract]                        
Computer, software, equipment and furniture, useful life               5 years        
Computers and software                        
Property, Plant and Equipment [Abstract]                        
Computer, software, equipment and furniture, useful life               4 years        
Furniture and Fixtures                        
Property, Plant and Equipment [Abstract]                        
Computer, software, equipment and furniture, useful life               5 years        
National Institute On Drug Abuse (NIDA)                        
Grant Revenue [Abstract]                        
Research and development arrangement contract to perform for others                   $ 1,020,000    
Revenue recognized on grant               $ 600,000     $ 1,020,000  
National Institute on Alcohol Abuse and Alcoholism (NIAAA)                        
Grant Revenue [Abstract]                        
Research and development arrangement contract to perform for others                 $ 1,000,000      
Revenue recognized on grant                     $ 132,000  
Employee Stock Purchase Plan (ESPP)                        
Restricted Cash                        
Certificate of deposit supporting lease obligation     $ 2,000         $ 2,000        
Sales Revenue | Product Concentration Risk                        
Concentration Risk                        
Concentration risk percentage               100.00%        
Accounts Payable | Vendor Concentration Risk                        
Concentration Risk                        
Concentration risk percentage               60.00%     70.00%  
Major Customer Number One | Sales Revenue | Customer Concentration Risk                        
Concentration Risk                        
Concentration risk percentage               40.00%        
Major Customer Number One | Accounts Receivable | Customer Concentration Risk                        
Concentration Risk                        
Concentration risk percentage               42.00%        
Major Customer Number Two | Sales Revenue | Customer Concentration Risk                        
Concentration Risk                        
Concentration risk percentage               25.00%        
Major Customer Number Two | Accounts Receivable | Customer Concentration Risk                        
Concentration Risk                        
Concentration risk percentage               26.00%        
Major Customer Number Three | Sales Revenue | Customer Concentration Risk                        
Concentration Risk                        
Concentration risk percentage               22.00%        
Major Customer Number Three | Accounts Receivable | Customer Concentration Risk                        
Concentration Risk                        
Concentration risk percentage               21.00%